Abstract
Overview
Introduction
Stress urinary incontinence (SUI) is the most common type of urinary
incontinence in women. Up until recently there were no globally developed or
widely approved pharmacological treatments for this disorder leaving women
with few treatment options-non-invasive (e.g. pelvic floor exercises) or
invasive (i.e. surgery) non-pharmacological therapy.
Scope
- Quantitative treatment data from 419 physicians based in US, Japan,
France, Germany, Italy, Spain and the UK; supported by key opinion leader
comments
- Analysis of epidemiology, presentation and referral patterns, diagnostic
assessment, and first- to third-line pharmacological treatments for SUI
- Influences on treatment choice and perception of current drug therapies
including duloxetine
- Evaluation of unmet needs and future outlook including awareness of R&D
drug pipeline
Report Highlights
Despite the high prevalence of SUI among women, a number of factors including
embarrassment and poor awareness amongst women act as a barrier to sufferers
seeking help for their condition. There is a need for better education and
treatment options to improve diagnosis and treatment rates.
Without the widespread availability of an efficacious drug for SUI, many
physicians have become reliant on non-pharmacological techniques. Patients and
primary care physicians, with little experience of surgery, are less likely to
be confident with this treatment option and it is here that pharmacological
treatments could gain more support.
The approval of Yentreve (duloxetine) for SUI in the EU has provided another
treatment option. However, uptake has not been as rapid as Lilly would have
hoped and although this may have been influenced by satisfaction with surgical
treatment, to date the available clinical data and experience in clinical
practice, has not always been positive.
Reasons to Purchase
- Forecast product sales by understanding key aspects of SUI epidemiology,
diagnosis and treatment
- Gain a better understanding of the challenges facing current and future
players in the SUI market
- Identify physicians key concerns in SUI including unmet needs and the
attributes that physicians believe are desirable for future treatments
| 
View Cart
